Received for publication May 15, 1991 The mouse corticotropin-releasing hormone (CRH) gene has been isolated and characterized by DNA sequence analysis.
The gene exhibits a structural organization similar to that of the human, rat, and ovine genes with two exons and an intervening sequence of 675 base pairs interrupting the 6' untranslated sequence of the mature mRNA. Analysis of the nucleotide sequence reveals that the mouse CRH peptide is identical at the amino acid level to the human and rat CRH peptides, with only three nucleotide changes between the rat and mouse sequences within the CRH peptide-encoding region. mechanisms controlling the expression of the CRH precursor and its gene is essential. These studies require the use of CRH cDNA and genomic sequences. The human, rat, and ovine CRH cDNA and genes have previously been isolated and sequenced (6-11). We are currently using transgenic mice to localize the &-acting DNA control elements responsible for the tissue-specific expression of the CRH gene. In order to clearly discriminate between the CRH transgene and the endogenous CRH gene, we have elucidated the entire nucleotide sequence of the mouse CRH gene including 336 bp of 5' flanking DNA. The mouse CRH gene is highly homologous to the rat CRH gene in all regions analyzed, while demonstrating high degrees of homology with the human and ovine CRH sequences in the 5' flanking DNA and CRH peptide-encoding regions. In fact, the predicted sequence of the mouse CRH peptide is identical at the amino acid level to the human and rat CRH peptides. Additionally, we demonstrate the expression of the mouse CRH gene in the mouse brain by in situ hybridization histochemistry.
MATERIALS AND METHODS

Screening of a Mouse Genomic DNA Library INTRODUCTION
The mammalian stress response is mediated in large part via the hypothalamic-anterior pituitary-adrenal (HPA) axis. The key hypothalamic-releasing factor in this axis is corticotropin-releasing hormone (CRH), a 41 amino acid peptide originally isolated and characterized by Vale and co-workers (1, 2). Release of CRH from the median eminence causes increased synthesis of proopiomelanocortin and secretion of adrenocorticotropin in the anterior pituitary, resulting in increased production of glucocorticoids in the adrenal cortex. In addition to the role of CRH in the HPA stress axis, CRH has also been shown to influence behavioral, neuroendocrine, and autonomic responses to stress within the central nervous system (3-5).
Because CRH plays such an important role in the body's response to stress, an understanding of the molecular A mouse genomic library (Clontech, mouse Balb/c liver) was plated on Escherichia coli NM 538 cells and screened in duplicate using a random primed rat CRH cDNA BamHI fragment (761 bp) as hybridization probe. This 761-bp BamHI fragment was isolated from the rat CRH cDNA clone (10) and subcloned into pGEM32 (Promega) to create pGEM3ZBam761.
Hybridization was carried out at 37°C in 50% formamide, 5X SSC, 25 mM sodium phosphate (pH 6.5), 5X Denhardts, 5 mMEDTA, 0.1% sodium pyrophosphate, and 0.1% SDS for 20 h. The filters were washed in 2X SSC, 0.1% SDS for 15 min each at 25 and 37°C followed by a 30-min wash in 0.5X SSC, 0.1% SDS at 48°C. The filters were autoradiographed for 60 h at -80°C with intensifying screens. Hybridization-positive plaques were picked and plaque-purified. Phage DNA was purified, digested with various restriction enzymes, and analyzed by Southern blotting using rat CRH genomic fragments for hybridization probes. Hybridization-positive mouse genomic DNA fragments were isolated and ligated into Ml3 or pUC vectors for restriction mapping, subcloning, and DNA sequencing. DNA sequencing was performed with Sequenase Version 2.0 (U.S. Biochemical) using dGTP and dITP mixes as described by the manufacturer. The Genetics Computer Group (GCG) Sequence Analysis Software Package (GAP program) was used for nucleotide homology determinations.
Southern Blot
Mouse genomic DNA was purified from mouse liver. DNA samples (20 pg) were digested with appropriate restriction enzymes and the resulting DNA fragments were separated on a 0.8% agarose gel in TEB buffer (89 m&f Tris base, 89 m&f boric acid, 2 mM EDTA, pH 8.2). The DNA was denatured and neutralized as described by Southern (12). The gel was transferred to Nytran (Schleicher and Schuell) and hybridized with either a mouse CRH 578-bp PstI DNA fragment (nick-translated) containing the mouse CRH peptide sequence (see Fig. 1 ) or the rat CRH 761-bp BamHI fragment (nick-translated) used for screening the genomic library. The blots were hybridized at 55°C (rat CRH probe) or 62°C (mouse CRH probe) for 18 h in 5X SSC, 25 n&f sodium phosphate (pH 6.5), 5X Denhardts, 5 mM EDTA, 0.1% sodium pyrophosphate, 0.1% SDS, and 50 pg/ml yeast RNA. The filters were washed two times at room temperature in 2X SSC, 0.1% SDS and then for 1 h at 55 or 62°C in 0.2X SSC, 0.1% SDS for the rat and mouse CRH probes, respectively. The filters were air-dried and exposed to Xray film at -80°C with intensifying screens.
In Situ Hybridization Analysis
Mouse brains were removed, frozen in 2-methylbutane, and stored at -80°C. The brains were sectioned (15-pm sections) and processed for in situ analysis as previously described (13) with the following minor modifications. After fixation of the sections for 1 h in cold buffered 4% paraformaldehyde followed by a 1-min 2X SSC wash, the sections were deproteinated batchwise in 1 pg/ml proteinase K for 10 min at 37°C. After deproteination, the sections were washed, acetylated, rinsed, and dehydrated as described (13). The 578-bp mouse PstI fragment containing the CRH peptide-encoding region was subcloned into pGem-4Z (Promega) and the resulting plasmid pGem4ZPst578 was linearized with Hi&II for preparation of antisense cRNA probe with SP6 polymerase or EcoRI for preparation of sense cRNA probe with T7 polymerase using [35S]UTP. Probe was diluted in hybridization buffer containing 75% formamide to yield l,OOO,OOO dpm/30 ~1 buffer. Sections were incubated at 54"C for 16-20 h. After digestion with RNase A (200 pg/ml) at 37°C for 30-60 min, the sections were washed successively in 2X SSC and 1X SSC for 5 min each followed by a 60-min wash in 0.5X SSC at 60°C. Sections were then dehydrated through alcohols and exposed to Kodak XAR-5 X-ray film for 48 h. Sections were then emulsion-dipped in Kodak NTB2 nuclear emulsion and exposed for 3-4 weeks.
RESULTS AND DISCUSSION
Isolation of the Mouse CRH Gene
Approximately 400,000 phage from the mouse genomic library were plated and screened with the 761-bp BamHI fragment of the rat CRH cDNA (Fig. 1) as described under Materials and Methods. Four hybridization-positive plaques were observed. DNA from these recombinant phage was purified, digested with various restriction endonucleases, and analyzed by Southern hybridization. Hybridization probes were selected from various regions of the rat CRH gene including 5' flanking DNA, exon I, and exon II sequences. Three of the genomic clones contained unique genomic DNA fragments. However, further analysis demonstrated that all three genomic clones contained common RsaI and PstI hybridization-positive restriction fragments, suggesting that the three clones contained different, but overlapping, genomic DNA fragments representing the same CRH gene.
Southern Analysis of Mouse Genomic DNA
To confirm the number of CRH genes present in the mouse genome and to verify the integrity of the genomic clones, a mouse genomic Southern was performed. Mouse genomic DNA was digested with a number of restriction endonucleases and subjected to Southern blot analysis as described under Materials and Methods. Hybridization with a nick-translated mouse CRH PstI fragment (578 bp containing the CRH peptide-encoding region) or a nick-translated rat CRH BamHI fragment (see Fig. 1 (data not shown). This hybridization pattern was precisely as expected due to the difference in nucleotide position of the two probes (see Fig. 1 Ml3 vectors for restriction enzyme mapping and nucleotide sequence analysis as shown in Fig. 1 . The complete nucleotide sequence of the mouse CRH gene is presented in Fig. 3 . The mouse CRH gene appears to contain two exons, with an intron of 675 base pairs. The mouse CRH cDNA has not yet been isolated and characterized, so the assignment of the two exons is based on similarity of the mouse CRH gene structure to that of the human, rat, and ovine CRH genes (9-11). Additionally, Northern blot analysis (data not shown) has demonstrated the presence of a 1.4-kb mouse CRH mRNA, similar to the sizes of the human and rat CRH mRNA. The exon/intron boundaries have been assigned by homology to the human, rat, and ovine genes and in accordance with the donor and acceptor rules as described by Breathnach et al. (14) .
The CRH mRNA cap sites have been mapped in ovine hypothalamus (9), human placenta (8, 15), and rat brain (R. C. Thompson, personal communication). The putative mouse CRH mRNA cap site has been assigned by homology to the rat, human, and ovine genes in addition to the position of the TATAA and CAAT boxes 26 and 60 nucleotides upstream. Preliminary RNase I protection analyses using mouse brain RNA show that the assigned cap site is utilized in the mouse, in addition to several minor upstream transcription initiation sites (data not shown). Heterogeneity of transcription initiation has also been demonstrated for the human (8) and rat CRH genes.
The 3' untranslated region of the mouse CRH gene contains three poly(A) addition signal sequences (AA-TAAA) at positions 1801, 2184, and 2247. The rat and ovine CRH genes each contain four poly(A) addition signal sequences (9, lo), with the first three sequences corresponding to those found in the mouse CRH gene. CRH hypothalamic cDNA clones have been isolated which utilize the first three signal sequences in the ovine (6) and the second and third signal sequences in the rat (7, 10). The human CRH gene contains only two poly(A) addition signal sequences corresponding to the second and third sequences found in the mouse CRH sequence (ll), and human placental CRH cDNA clones utilize the more 3' of the two signal sequences (8). The functional significance of the multiple poly(A) addition signal sequences in the CRH gene has not been explored.
The amino acid sequence of the mouse CRH peptide was predicted based on the nucleotide sequence of the mouse CRH gene. As shown in Fig. 4 , the mouse CRH peptide is identical at the amino acid level to the rat and human CRH peptides. Within the peptide-encoding region, the mouse gene contains 3 nucleotide changes from the rat DNA sequence (98% homologous) and 10 nucleotide changes from the human gene (92% homologous), none of which cause an alteration in amino acid. The ovine CRH peptide contains 7 amino acid substitutions from the mouse, rat, and human CRH peptides. homologous to all regions of the rat sequence, with the lowest level of homology being 89% in the intronic sequences. In contrast, the mouse CRH gene shows high levels of homology to both the human and the ovine sequences in only two regions, the CRH peptide-encoding sequence and the 5' flanking genomic sequences.
The mouse CRH 5' flanking sequence is greater than 92% homologous at the nucleic acid level to the rat, human, and ovine CRH genes over the first 336 bp 5' to the mRNA cap site, more highly conserved than even the CRH peptide-encoding region. This nucleic acid sequence homology is shown in detail in Fig. 5 . The 5' flanking region of genes often contain transcriptional control elements responsible for tissue-specific, developmental, and hormonal regulation. The high degree of homology seen in this region of the CRH genes suggests that this DNA sequence has been conserved through evolution to maintain the important regulation of the CRH gene. Within this sequence are the TATAA and CAAT boxes at 26 and 60 nucleotides 5' to the mRNA cap site. Additional TA-TAA and CAAT boxes are present further upstream and are conserved in all four CRH genes. Additionally, a 59-bp DNA fragment which mediates CAMP regulation has been localized in the rat CRH gene (16) and the CAMPresponsive element (CRE) consensus sequence (TGACGTCA) within the localized DNA fragment is 100% homologous in all four species, suggesting that it may function in CAMP regulation of CRH expression in the rat, mouse, human, and ovine. A similar comparison of the CRE in the glycoprotein hormone a-subunit gene from human, horse, rat, and mouse has shown that a one nucleotide change within the CRE consensus sequence can dramatically alter the CAMP regulation and tissuespecific expression of that gene (17).
The high level of homology within the 5' flanking sequence of the CRH gene suggests that additional transcriptional control elements may also be present within this 336-bp DNA sequence. It is interesting to note that the level of homology between the four CRH genes decreases as one moves upstream from position -336. Although the rat and mouse sequences are still relatively well conserved, the homology decreases dramatically between mouse and human or mouse and ovine, finding much smaller regions of homology interspersed with more divergent sequences.
In Situ Hybridization Histochemical Localization of CRH Expression in Mouse Brain
Immunocytochemical studies have demonstrated that the CRH peptide is present in widespread regions of the rat brain as well as in some peripheral tissues (18-23). CRH mRNA has been detected by Northern blot analysis in the hypothalamus, brain stem, cerebral cortex, midbrain, striatum, hippocampus, and olfactory bulb of the rat brain, as well as in rat spinal cord, adrenal, and testis (10, (24) (25) (26) . In situ hybridization histochemical analyses in the rat have demonstrated the presence of CRH mRNA in the paraventricular nucleus of the hypothalamus, as well as in the inferior olivary nucleus and Barrington's nucleus (13, 25, (27) (28) (29) . In the mouse, CRH immunoreactivity has been detected in extracts of the median eminence, hypothalamus, amygdala, thalamus, frontal cortex, medulla/pans, and cerebellum by radioimmunoassay (30,31), but mouse CRH mRNA levels have not previously been analyzed. Mouse brain, liver, lung, and spleen RNA were isolated and tested for CRH mRNA by RNase protection and Northern blot analyses. In both cases, CRH mRNA was detected only in mouse brain RNA (data not shown). In order to more carefully examine the expression of mouse CRH mRNA in brain, in situ hybridization analysis was performed using mouse brain sections containing the paraventricular nucleus of the hypothalamus or the inferior olive complex. As shown in Fig. 6 , anti-sense mouse CRH probe hybridized to CRH mRNA in the parvocellular paraventricular nucleus of the hypothalamus (Fig. 6B ) and in the medial accessory olivary nucleus (Fig. 6D ) of the mouse brain. Hybridization was observed in both the principal and the accessory olivary nuclei of the mouse. Control experiments using sense hybridization probe showed no detectable expression in the paraventricular nucleus or inferior olivary complex. These results demonstrate that CRH is expressed in several of the same nuclei in the rat and mouse, suggesting that it functions as both a hypothalamic-releasing factor for ACTH in the anterior pituitary and a neurotransmitter or neuromodulator in the central nervous system of both species.
